Valproate risk minimisation materials

Epilim (sodium valproate) and Depakote (valproate semisodium) 

Summaries of product characteristics & patient information leaflets

By clicking on the medicine names in the list below you will leave the website and will go to the website which is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. The existence of a link between this website and any third party site or resource in no way implies that Sanofi in any way approves of the content of these sites or resources, or any use to which such content maybe put. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our Cookie Policy.
By closing this message and/or continuing to use the website, you consent to our use of cookies on this device in accordance with our Cookie Policy unless you have disabled them.

Accept and close